Trial Profile
A Randomized, Open Label Parallel Controlled, Multicenter Study to Evaluate Safety and Efficacy of Posaconazole Oral Suspension Vs. Fluconazole (Capsule) in High-risk Leukopenic Patients for Prevention of Invasive Fungal Infection
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 May 2022
Price :
$35
*
At a glance
- Drugs Posaconazole (Primary) ; Fluconazole
- Indications Mycoses
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 13 Mar 2015 New trial record